Is Gain Therapeutics, Inc. (GANX) a Buy, Sell, or Hold?
NASDAQ : GANX
Gain Therapeutics, Inc.
$1.655 USD
-$0.03 (-1.49%)
- Volume
- 230.94K
- Average Volume
- 885.42K
- Market Capitalization
- $70.59M
- P/E Ratio
- -2.85
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $4.34
- Year Low
- $1.41
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.69
GANX vs. The Competition
| Properties | GANX | ACET | ADAG | CRVO |
|---|---|---|---|---|
| Market Cap | $70.59M | $79.46M | $139.73M | $28.42M |
| Shares Outstanding | $42.65M | $9.35M | $37.65M | $9.26M |
| P/E Ratio | -2.85 | -0.57 | -7.87 | -0.94 |
| EPS | -0.5 | -10.13 | -0.47 | -3.24 |
| Day Low | 1.625 | 8.4165 | 3.6172 | 2.88 |
| Day high | 1.67 | 8.67 | 3.8 | 3.21 |
| Year Low | 1.41 | 6.01 | 1.3 | 2.13 |
| Year High | 4.34 | 17.44 | 4.85 | 13.13 |
| Average Price 50 | 1.7974 | 8.245 | 3.756 | 3.3358 |
| Average Price 200 | 2.20618 | 8.90352 | 2.86854 | 5.5506 |
| Volume | 230.94K | 23685.84 | 16871.25 | 2.2M |
| Average Volume | - | - | - | - |